Impact of DNA amplification on gene expression patterns in breast cancer

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift


Genetic changes underlie tumor progression and may lead to cancer-specific expression of critical genes. Over 1100 publications have described the use of comparative genomic hybridization (CGH) to analyze the pattern of copy number alterations in cancer, but very few of the genes affected are known. Here, we performed high-resolution CGH analysis on cDNA microarrays in breast cancer and directly compared copy number and mRNA expression levels of 13,824 genes to quantitate the impact of genomic changes on gene expression. We identified and mapped the boundaries of 24 independent amplicons, ranging in size from 0.2 to 12 Mb. Throughout the genome, both high- and low-level copy number changes had a substantial impact on gene expression, with 44% of the highly amplified genes showing overexpression and 10.5% of the highly overexpressed genes being amplified. Statistical analysis with random permutation tests identified 270 genes whose expression levels across 14 samples were systematically attributable to gene amplification. These included most previously described amplified genes in breast cancer and many novel targets for genomic alterations, including the HOXB7 gene, the presence of which in a novel amplicon at 17q21.3 was validated in 10.2% of primary breast cancers and associated with poor patient prognosis. In conclusion, CGH on cDNA microarrays revealed hundreds of novel genes whose overexpression is attributable to gene amplification. These genes may provide insights to the clonal evolution and progression of breast cancer and highlight promising therapeutic targets.


  • Elizabeth Hyman
  • Paivikki Kauraniemi
  • Sampsa Hautaniemi
  • Maija Wolf
  • Spyro Mousses
  • Ester Rozenblum
  • Markus Ringnér
  • Guido Sauter
  • Outi Monni
  • Abdel Elkahloun
  • Olli-P Kallioniemi
  • Anne Kallioniemi
Externa organisationer
  • Tampere University Hospital

Ämnesklassifikation (UKÄ) – OBLIGATORISK

  • Cancer och onkologi
Sidor (från-till)6240-6245
TidskriftCancer Research
StatusPublished - 2002
Peer review utfördJa
Externt publiceradJa